Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study-Reference-Cited by-同舟云学术

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study

Published:2009-12-30 Issue:4 Volume:3 Page:298-305
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut Liver

Author:

Park Jongha,Kim Myung-Hwan,Kim Kyu-pyo,Park Do Hyun,Moon Sung-Hoon,Song Tae Jun,Eum Junbum,Lee Sang Soo,Seo Dong Wan,Lee Sung Koo

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2009/003/gnl-3-298.pdf

Reference41 articles.

1. Biliary Tract Cancers

2. Cholangiocarcinoma

3. Mortality from hepatocellular and biliary cancers: changing epidemiological trends

4. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

5. A Review and Update on Cholangiocarcinoma

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable Response to Pembrolizumab and Lenvatinib in a Patient with Chemotherapy-refractory Cholangiocarcinoma;Archives of Cancer Science and Therapy;2024-07-15

2. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma;Pharmaceuticals;2024-07-08

3. Beyond the Bile: Exploring the Microbiome and Metabolites in Cholangiocarcinoma;Life;2024-05-29

4. Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma;Frontiers in Immunology;2024-05-10

5. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma;World Journal of Gastroenterology;2024-03-07